Treatment Information

Back

Liver Cancer treatment details. Chemotherapy, Biologic therapy.

Zhengzhou University Affiliated Cancer Hospital, Zhengzhou, Henan, China.

Survival: monthsCountry:China
Toxiciy Grade:4City/State/Province:Zhengzhou, Henan
Treatments:Chemotherapy, Biologic therapyHospital:Zhengzhou University Affiliated Cancer Hospital
Drugs:Journal:Link
Date:Feb 2015

Description:

Patients:
This study involved 49 advanced hepatocellular carcinoma patients who had not been previously treated. The median patient age was 54 years and 75.5% were male.

Treatment:
Patients received chemotherapy with gemcitabine and oxaliplatin, and biologic therapy with sorafenib.

Toxicities:
The most severe toxicities were grade 4 heart attack and neutropenia. Grade 3 fatigue, appetite loss, and hand-foot skin reaction were also reported.

Results:
The median overall survival was 15.7 months.

Support:
This study was partially supported by Sanofi Aventis.

Correspondence: Dr. Jufeng Wang; email: [email protected]



Back